Extracellular release of damaged mitochondria induced by prehematopoietic stem cell transplant conditioning exacerbates GVHD

•Pretransplant conditioning regimens induces release of damaged extracellular mitochondria independent of cell death.•Presence of circulating extracellular mitochondria activates host antigen-presenting cells and aggravates graft-versus-host disease. [Display omitted] Despite therapeutic advancement...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood advances 2024-07, Vol.8 (14), p.3691-3704
Hauptverfasser: Vijayan, Vijith, Yan, Hao, Lohmeyer, Juliane K., Prentiss, Kaylin A., Patil, Rachna V., Barbarito, Giulia, Lopez, Ivan, Elezaby, Aly, Peterson, Kolten, Baker, Jeanette, Ostberg, Nicolai P., Bertaina, Alice, Negrin, Robert S., Mochly-Rosen, Daria, Weinberg, Kenneth, Haileselassie, Bereketeab
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Pretransplant conditioning regimens induces release of damaged extracellular mitochondria independent of cell death.•Presence of circulating extracellular mitochondria activates host antigen-presenting cells and aggravates graft-versus-host disease. [Display omitted] Despite therapeutic advancements, graft-versus-host disease (GVHD) is a major complication of hematopoietic stem cell transplantation (HSCT). In current models of GVHD, tissue injury induced by cytotoxic conditioning regimens, along with translocation of microbes expressing pathogen-associated molecular patterns, result in activation of host antigen-presenting cells (APCs) to stimulate alloreactive donor T lymphocytes. Recent studies have demonstrated that in many pathologic states, tissue injury results in the release of mitochondria from the cytoplasm to the extracellular space. We hypothesized that extracellular mitochondria, which are related to archaebacteria, could also trigger GVHD by stimulation of host APCs. We found that clinically relevant doses of radiation or busulfan induced extracellular release of mitochondria by various cell types, including cultured intestinal epithelial cells. Conditioning-mediated mitochondrial release was associated with mitochondrial damage and impaired quality control but did not affect the viability of the cells. Extracellular mitochondria directly stimulated host APCs to express higher levels of major histocompatibility complex II (MHC-II), costimulatory CD86, and proinflammatory cytokines, resulting in increased donor T-cell activation, and proliferation in mixed lymphocyte reactions. Analyses of plasma from both experimental mice and a cohort of children undergoing HSCT demonstrated that conditioning induced extracellular mitochondrial release in vivo. In mice undergoing MHC-mismatched HSCT, administration of purified syngeneic extracellular mitochondria increased host APC activation and exacerbated GVHD. Our data suggest that pre-HSCT conditioning results in extracellular release of damaged mitochondria, which increase alloreactivity and exacerbate GVHD. Therefore, decreasing the extracellular release of damaged mitochondria after conditioning could serve as a novel strategy for GVHD prevention.
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2023012328